Few important points:
- BRL has JV company with Nissan Chemical Ltd Japan. The company named as Nissan Bharat Rasayan Pvt Ltd (NBRL) has started its manufacturing operations from February 2023 at its very modern and automated facility at Sayakha, Gujarat. Major focus of this unit will be manufacturing of patented molecules for global requirement.
- Bharat has expanded its production capacity both at Mokhra-Haryana and Dahej Gujarat manufacturing plant. We have also finalized a new greenfield manufacturing unit-3 at Dahej Gujarat which will start commercial production by end of 2024 as part of our further backward integration strategy along with focus on contract manufacturing for our MNC and Japanese partners.
We also started formulation production in our second state-of-art greenfield facility at Panoli Gujarat spread across 8 acres to cater increasing demand for packed (P2P – pack to pack) formulation products by both domestic and global customers. Some of the new formulations which we can formulate include OD, ME, SC, WDG, WG, SE, ULV, SL apart from normal generic products.
New products which were launched by us in last couple of years includes: Penoxsulam, Tolfenpyrad, Pymetrozine, and Zeta Cypermethrin apart from some patented intermediates and technical as part of CRAMP business - Bharat Rasayan Ltd. (BRL), one constituent company of Bharat Group, invested in global registrations (particularly in restricted market) as a part of long-term strategy and we were able to get registration of Bifenthrin, Metribuzin and Lambda Cyhalothrin in Brazil market and also got EPA registration in US market for Bifenthrin, Metribuzin, Lambda cyhalothrin, Sulfosulfuron and Zeta Cypermethrin.
Disc: Invested for over 5 years
Subscribe To Our Free Newsletter |